Medicare boosts CAR-T cancer therapies with expanded coverage

CMS also broadened the settings in which the pricey therapies would be covered, applying its final rule to use in "healthcare facilities" rather than explicitly in hospitals.

Source: Healthcare Dive, https://www.healthcaredive.com